Trial · NCT02354508
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1: Core Phase | STARTED | Lanreotide 120 mg | 41 | |
| Period 1: Core Phase | STARTED | Octreotide 30 mg | 29 | |
| Period 1: Core Phase | STARTED | Octreotide 40 mg | 53 | |
| Period 1: Core Phase | COMPLETED | Lanreotide 120 mg | 39 | |
| Period 1: Core Phase | COMPLETED | Octreotide 30 mg | 27 | |
| Period 1: Core Phase | COMPLETED | Octreotide 40 mg | 47 | |
| Period 1: Core Phase | NOT COMPLETED | Lanreotide 120 mg | 2 | |
| Period 1: Core Phase | NOT COMPLETED | Octreotide 30 mg | 2 | |
| Period 1: Core Phase | NOT COMPLETED | Octreotide 40 mg | 6 | |
| Period 2: Extension Phase | STARTED | Lanreotide 120 mg | 26 | |
| Period 2: Extension Phase | STARTED | Octreotide 30 mg | 23 | |
| Period 2: Extension Phase | STARTED | Octreotide 40 mg | 39 | |
| Period 2: Extension Phase | COMPLETED | Lanreotide 120 mg | 20 | |
| Period 2: Extension Phase | COMPLETED | Octreotide 30 mg | 19 | |
| Period 2: Extension Phase | COMPLETED | Octreotide 40 mg | 36 | |
| Period 2: Extension Phase | NOT COMPLETED | Lanreotide 120 mg | 6 | |
| Period 2: Extension Phase | NOT COMPLETED | Octreotide 30 mg | 4 | |
| Period 2: Extension Phase | NOT COMPLETED | Octreotide 40 mg | 3 | |
| Period 3: Post-treatment Follow up Phase | STARTED | Lanreotide 120 mg | 26 | |
| Period 3: Post-treatment Follow up Phase | STARTED | Octreotide 30 mg | 23 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02354508/flow